BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34520312)

  • 1. Bilateral Multiple Retinal Detachments Associated with Diffuse Large B-Cell Lymphoma: Masquerading as Vogt-Koyanagi-Harada Disease.
    Lee KE; Kim YJ
    Ocul Immunol Inflamm; 2023 Jan; 31(1):7-10. PubMed ID: 34520312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoblastic leukemia manifesting as acute Vogt-Koyanagi-Harada disease.
    Yang HK; Yu HG
    Korean J Ophthalmol; 2009 Dec; 23(4):325-8. PubMed ID: 20046700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral retinal detachment in a patient with Vogt-Koyanagi-Harada syndrome.
    McGehee BE; Chaljub G; Shah RK; Oto A; Camacho AC; Tang RA
    Emerg Radiol; 2005 Nov; 11(6):366-71. PubMed ID: 16237574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.
    Reibaldi M; Russo A; Avitabile T; Uva MG; Franco L; Longo A; Toro MD; Cennamo G; Mariotti C; Neri P; Noci ND; Russo V
    Retina; 2014 Mar; 34(3):490-6. PubMed ID: 23903795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic non-Hodgkin's lymphoma masquerading as Vogt-Koyanagi-Harada disease in an HIV-positive patient.
    Mathai A; Lall A; Jain R; Pathengay A
    Clin Exp Ophthalmol; 2006 Apr; 34(3):280-2. PubMed ID: 16671912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
    Lu S; Taban M
    Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
    Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
    Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vogt-Koyanagi-Harada syndrome in children - a case report].
    Bušányová B; Tomčíková D; Gerinec A
    Cesk Slov Oftalmol; 2013 Jun; 69(2):81-6. PubMed ID: 23964873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suprachoroidal triamcinolone acetonide injection: a novel therapy for serous retinal detachment due to Vogt-Koyanagi Harada disease.
    Tabl AA; Elsayed MA; Tabl MA
    Eur J Ophthalmol; 2022 Nov; 32(6):3482-3488. PubMed ID: 35266801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
    Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
    BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrolental Bullous Retinal Detachment as the Presenting Feature of Vogt-Koyanagi-Harada Disease in an Elderly Indian Female: Diagnostic and Therapeutic Challenge.
    Kumar Menia N; Bansal R; Gupta V
    Ocul Immunol Inflamm; 2024 May; 32(4):429-432. PubMed ID: 36897931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
    Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
    Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
    Fukutsu K; Namba K; Iwata D; Mizuuchi K; Kase S; Suzuki K; Shimizu H; Shibata Y; Yamawaki F; Onozawa M; Ishida S
    BMC Ophthalmol; 2020 Mar; 20(1):94. PubMed ID: 32156266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
    Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
    Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutton fat-like subretinal precipitates associated with Vogt-Koyanagi-Harada disease.
    Hamabata K; Hashizume K; Ishikawa Y; Fujiwara T; Machida S; Kurosaka D
    Ocul Immunol Inflamm; 2010 Jan; 18(1):44-5. PubMed ID: 20128649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
    Park HS; Nam KY; Kim JY
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vogt-Koyanagi-Harada syndrome Case report.
    Nicula C; Szabo I
    Rom J Ophthalmol; 2016; 60(3):181-183. PubMed ID: 29450345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    Zhang Q; Fan X; Tian M; Han H
    BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.